← Oncology Approval Tracker

FDA DECISION ·

Cotellic

cobimetinib · Genentech

FDA approvalNew or expanded indicationHistiocytic neoplasms
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Single-agent treatment for adults with histiocytic neoplasms.

LAMPGEN ANALYSIS

Why it matters

The action extends MEK inhibition to adult histiocytic neoplasms.

What research teams should watch

Confirm specialist pathology review and create a plan to track disease response across potentially multiple involved organs.

PRIMARY RECORDS

Sources